235 related articles for article (PubMed ID: 25633652)
21. Pleuritis and Pericarditis in Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis.
Thompson GE; Bourne MH; Casal Moura M; Baqir M; Cartin-Ceba R; Makol A; Koster MJ; Warrington KJ; Borah BJ; Specks U
Chest; 2021 Aug; 160(2):572-581. PubMed ID: 33667492
[TBL] [Abstract][Full Text] [Related]
22. Does geographic location affect incidence of ANCA-associated renal vasculitis in northern Saskatchewan, Canada?
Anderson K; Klassen J; Stewart SA; Taylor-Gjevre RM
Rheumatology (Oxford); 2013 Oct; 52(10):1840-4. PubMed ID: 23838025
[TBL] [Abstract][Full Text] [Related]
23. BVAS version 3 and BVAS/GPA: standing on the same line?
Ahn SS; Ha JW; Park YB; Lee SW
Clin Rheumatol; 2022 Nov; 41(11):3429-3437. PubMed ID: 35804274
[TBL] [Abstract][Full Text] [Related]
24. Red Blood Cell Distribution Width Can Predict Vasculitis Activity and Poor Prognosis in Granulomatosis with Polyangiitis.
Kim HJ; Yoo J; Jung SM; Song JJ; Park YB; Lee SW
Yonsei Med J; 2018 Mar; 59(2):294-302. PubMed ID: 29436199
[TBL] [Abstract][Full Text] [Related]
25. Remission and Low Disease Activity in Granulomatosis With Polyangiitis and Microscopic Polyangiitis: Prevalence and Impact on Damage Accrual.
Delvino P; Sardanelli F; Monti S; Cohen P; Puéchal X; Mouthon L; Montecucco C; Guillevin L; Terrier B
Arthritis Care Res (Hoboken); 2023 May; 75(5):1158-1165. PubMed ID: 35604889
[TBL] [Abstract][Full Text] [Related]
26. Interleukin-6 in ANCA-associated vasculitis: Rationale for successful treatment with tocilizumab.
Berti A; Cavalli G; Campochiaro C; Guglielmi B; Baldissera E; Cappio S; Sabbadini MG; Doglioni C; Dagna L
Semin Arthritis Rheum; 2015 Aug; 45(1):48-54. PubMed ID: 25841802
[TBL] [Abstract][Full Text] [Related]
27. Rituximab for remission induction in elderly patients with ANCA-associated vasculitis.
Timlin H; Lee SM; Manno RL; Seo P; Geetha D
Semin Arthritis Rheum; 2015 Aug; 45(1):67-9. PubMed ID: 25796088
[TBL] [Abstract][Full Text] [Related]
28. Childhood GPA, EGPA, and MPA.
Jariwala M; Laxer RM
Clin Immunol; 2020 Feb; 211():108325. PubMed ID: 31837445
[TBL] [Abstract][Full Text] [Related]
29. Neutrophilic Dermatoses in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A French Multicenter Study of 17 Cases and Literature Review.
de Boysson H; Martin Silva N; de Moreuil C; Néel A; de Menthon M; Meyer O; Launay D; Pagnoux C; Guillevin L; Puéchal X; Bienvenu B; Aouba A;
Medicine (Baltimore); 2016 Mar; 95(11):e2957. PubMed ID: 26986103
[TBL] [Abstract][Full Text] [Related]
30. Inflammatory bowel diseases in anti-neutrophil cytoplasmic antibody-associated vasculitides: 11 retrospective cases from the French Vasculitis Study Group.
Humbert S; Guilpain P; Puéchal X; Terrier B; Rivière S; Mahr A; Pagnoux C; Bagnères D; Cordier JF; Le Quellec A; Altwegg R; Guillevin L;
Rheumatology (Oxford); 2015 Nov; 54(11):1970-5. PubMed ID: 26106214
[TBL] [Abstract][Full Text] [Related]
31. Childhood- versus adult-onset ANCA-associated vasculitides: A nested, matched case-control study from the French Vasculitis Study Group Registry.
Iudici M; Pagnoux C; Quartier P; Büchler M; Cevallos R; Cohen P; de Moreuil C; Guilpain P; Le Quellec A; Serratrice J; Terrier B; Guillevin L; Mouthon L; Puéchal X;
Autoimmun Rev; 2018 Feb; 17(2):108-114. PubMed ID: 29180123
[TBL] [Abstract][Full Text] [Related]
32. Biological drugs in ANCA-associated vasculitis.
Lutalo PM; D'Cruz DP
Int Immunopharmacol; 2015 Aug; 27(2):209-12. PubMed ID: 25907243
[TBL] [Abstract][Full Text] [Related]
33. Echocardiographic features in patients with ANCA-associated vasculitis within 3 months before and after diagnosis.
Ahn SS; Park ES; Jung SM; Song JJ; Park YB; Lee SW
Clin Rheumatol; 2017 Dec; 36(12):2751-2759. PubMed ID: 28988280
[TBL] [Abstract][Full Text] [Related]
34. [Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis: advances in pathogenesis and treatment].
Silva F; Cisternas M
Rev Med Chil; 2013 Jun; 141(6):765-73. PubMed ID: 24121580
[TBL] [Abstract][Full Text] [Related]
35. ANCA-associated vasculitis in patients with primary Sjögren's syndrome: detailed analysis of 7 new cases and systematic literature review.
Guellec D; Cornec-Le Gall E; Groh M; Hachulla E; Karras A; Charles P; Dunogué B; Abad S; Alvarez F; Gérard F; Devauchelle-Pensec V; Pers JO; Puéchal X; Guillevin L; Saraux A; Cornec D;
Autoimmun Rev; 2015 Aug; 14(8):742-50. PubMed ID: 25916811
[TBL] [Abstract][Full Text] [Related]
36. Peripheral neuropathy in ANCA-associated vasculitis: outcomes from the European Vasculitis Study Group trials.
Suppiah R; Hadden RD; Batra R; Arden NK; Collins MP; Guillevin L; Jayne DR; Luqmani RA;
Rheumatology (Oxford); 2011 Dec; 50(12):2214-22. PubMed ID: 21890618
[TBL] [Abstract][Full Text] [Related]
37. Renal involvement in anti-neutrophil cytoplasmic autoantibody associated vasculitis.
Sinico RA; Di Toma L; Radice A
Autoimmun Rev; 2013 Feb; 12(4):477-82. PubMed ID: 22921791
[TBL] [Abstract][Full Text] [Related]
38. Incidence of PR3- and MPO-ANCA autoantibody specificity changes in ANCA-associated vasculitis.
Holding S; Fisher VJ; Abuzakouk M
Ann Clin Biochem; 2015 Mar; 52(Pt 2):297-301. PubMed ID: 24723621
[TBL] [Abstract][Full Text] [Related]
39. Clinical presentation and outcome prediction of clinical, serological, and histopathological classification schemes in ANCA-associated vasculitis with renal involvement.
Córdova-Sánchez BM; Mejía-Vilet JM; Morales-Buenrostro LE; Loyola-Rodríguez G; Uribe-Uribe NO; Correa-Rotter R
Clin Rheumatol; 2016 Jul; 35(7):1805-16. PubMed ID: 26852317
[TBL] [Abstract][Full Text] [Related]
40. Prevalence of overlap of antineutrophil cytoplasmic antibody associated vasculitis with systemic autoimmune diseases: an unrecognized example of poliautoimmunity.
Martín-Nares E; Zuñiga-Tamayo D; Hinojosa-Azaola A
Clin Rheumatol; 2019 Jan; 38(1):97-106. PubMed ID: 30006919
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
